Where does Eximis Surgical Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Eximis Surgical Inc. ranks #26,271 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Eximis Surgical Inc. hold?

Eximis Surgical Inc. holds 10 US utility patents granted between 2016 and 2025, spanning 2 technology areas.

What is Eximis Surgical Inc.'s Innovation Score?

Eximis Surgical Inc. has an Innovation Score of 35.7 out of 100 (top 49% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Eximis Surgical Inc. focus on?

Eximis Surgical Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 10 patents, ranking #1,719 of 7,127 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

Is Eximis Surgical Inc.'s patent grant rate increasing or decreasing?

Eximis Surgical Inc.'s recent grant velocity is +250% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Eximis Surgical Inc.'s patents?

Eximis Surgical Inc.'s patents average 22.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Eximis Surgical Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Eximis Surgical Inc.

USPTO PatentsView assignee record - 10 granted patents across 2 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Eximis ranks #26,271 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 2 technology areas.

#26,271
of 49,997 US assignees by volume: Top 49%
by Innovation Score (35.7/100): 22.5
avg claims per patent: +250%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26271 · US Corporation #26,271 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,271/49,997
PHOTO-FINISH Evelyn & Bobbie
CPC-NARROW A61B · 2 areas
INNOV-THIN 35.7/100
CLAIMS-DENSE 22.5 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +250% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Evelyn & Bobbie, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Eximis’s 35.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (23%) Velocity 8.9 pts (25%) Breadth 5.0 pts (14%) Claim depth 13.5 pts (38%)

Qualcomm Incorporated · highest

85
Eximis Surgical · this assignee

36
3D Lighting… · lowest

7

What this shows Eximis's Innovation Score is 35.7/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Eximis?

Each dot is one of Eximis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Eximis’s own 22.5 claims/patent is ABOVE the 16.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Eximis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Eximis's grants concentrate

Eximis Surgical Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2016. By volume, Eximis sits between Evelyn & Bobbie, LLC and EYE Labs, LLC.

Eximis's three-year grant acceleration

Eximis Surgical Inc. shows 4 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Evelyn & Bobbie

10
Everheart Systems

10
Evotec Internatio…

10
Exacto

10
Exostem Biotec

10
Exro

10
Exten

10
EYE Labs

10
Eximis Surgical ◀

10

What this shows Eximis holds 10 patents at rank #26,218, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Eximis

By rank, the assignees closest to #26,218 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Eximis's primary technology class.

Eximis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Eximis Surgical Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	10.0%
2017	1	10.0%
2020	2	20.0%
2021	1	10.0%
2022	1	10.0%
2023	1	10.0%
2024	2	20.0%
2025partial year	1	10.0%

Which technologies does Eximis Surgical Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 10

H01R - Electrically-conductive CONNECTIONS; Structural Associations OF A Plurality OF Mutually-insulated Electrical Connecting ELEMENTS; Coupling DEVICES; Current Collectors 2

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Eximis Surgical Inc.'s patent record in context - here's where to go next.

Eximis Surgical Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #26,271 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Eximis Surgical Inc. against Evelyn & Bobbie, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.